Patents by Inventor Amy WALKER

Amy WALKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260159827
    Abstract: The present invention relates to the purification of linear DNA products, which may have nuclease-resistance. The linear DNA products may be double-stranded or single stranded. In addition, the present invention relates to purified linear DNA products, and their uses.
    Type: Application
    Filed: November 2, 2023
    Publication date: June 11, 2026
    Inventors: Heikki Lanckriet, Ángel Picher, Amy Walker
  • Publication number: 20260035723
    Abstract: Protected DNA comprising a single-stranded DNA (ssDNA) cassette is provided. Further provided are uses of the protected DNA, methods for producing protected DNA, products generated in performing such methods (including intermediate and final products), and kits for use in such methods.
    Type: Application
    Filed: July 19, 2023
    Publication date: February 5, 2026
    Inventors: Heikki Lanckriet, Ángel Picher, Amy Walker, Amine Bouchareb
  • Publication number: 20260021197
    Abstract: Nanoparticles suitable for delivery of a cargo to a chondrocyte, and targeting peptides comprising a chondrocyte targeting sequence, are provided. Further provided are uses of the nanoparticles and targeting peptides, for example, in treating a joint or cartilage disease or disorder.
    Type: Application
    Filed: July 31, 2023
    Publication date: January 22, 2026
    Inventors: Amy Walker, Heikki Lanckriet, Ángel Picher, Ana Vanina Hangu, William Thompson
  • Publication number: 20250345278
    Abstract: Nanoparticles suitable for delivery of a linear DNA molecule are provided. Nanoparticles suitable for delivery of mRNA or DNA are provided. Further provided are uses of the nanoparticles including the use of the nanoparticles for treating disease and the use of the nanoparticles in vaccines.
    Type: Application
    Filed: February 1, 2024
    Publication date: November 13, 2025
    Inventors: Heikki Lanckriet, Amy Walker, Ángel Picher, Emily Young, Yu Lu
  • Publication number: 20250171781
    Abstract: The present invention relates to linear double-stranded DNA products comprising nuclease-resistant nucleotides at internal positions in each strand. In addition, the present invention relates to complex molecules, nanoparticles, compositions and libraries comprising the linear double-stranded DNA products. Also provided are methods for producing and using the linear double-stranded DNA products.
    Type: Application
    Filed: February 14, 2025
    Publication date: May 29, 2025
    Inventors: Heikki Lanckriet, Ángel Picher, Amy Walker
  • Publication number: 20250099611
    Abstract: Nanoparticles suitable for delivery of a linear DNA molecule (e.g. a closed linear DNA molecule) to a target cell are provided. Further provided are uses of the nanoparticles including the use of the nanoparticles for treating disease.
    Type: Application
    Filed: July 29, 2022
    Publication date: March 27, 2025
    Inventors: Amy Walker, Heikki Lanckriet, Ángel Picher
  • Publication number: 20240360488
    Abstract: Methods for producing a linear deoxyribonucleic acid (DNA) product with enhanced resistance to nuclease digestion are provided.
    Type: Application
    Filed: February 1, 2024
    Publication date: October 31, 2024
    Inventors: Heikki Lanckriet, Amy Walker, Ángel Picher
  • Publication number: 20240358846
    Abstract: Nanoparticles suitable for delivery of a cargo to a muscle cell, and targeting peptides comprising a muscle cell targeting sequence, are provided. Further provided are uses of the nanoparticles and targeting peptides, for example, in treating a muscle disease or disorder such as a skeletal muscle disease or disorder or a heart disease or disorder.
    Type: Application
    Filed: July 29, 2022
    Publication date: October 31, 2024
    Inventors: Amy Walker, Heikki Lanckriet, Ángel Picher, Elena Dyankova
  • Publication number: 20240209362
    Abstract: The present invention relates to linear double-stranded DNA products comprising nuclease-resistant nucleotides at internal positions in each strand. In addition, the present invention relates to complex molecules, nanoparticles, compositions and libraries comprising the linear double-stranded DNA products. Also provided are methods for producing and using the linear double-stranded DNA products.
    Type: Application
    Filed: April 29, 2022
    Publication date: June 27, 2024
    Inventors: Heikki Lanckriet, Ángel Picher, Amy Walker
  • Publication number: 20240076659
    Abstract: Methods for producing a linear deoxyribonucleic acid (DNA) product with enhanced resistance to nuclease digestion are provided. The methods comprise: (a) contacting a double-stranded DNA molecule with an endonuclease, a ligase and first and second adaptor molecules to form a single contiguous aqueous volume; and (b) incubating the single contiguous aqueous volume to generate a linear DNA product. There are also provided linear deoxyribonucleic acid (DNA) products with enhanced resistance to nuclease digestion and uses thereof.
    Type: Application
    Filed: July 29, 2022
    Publication date: March 7, 2024
    Inventors: Ángel Picher, Heikki Lanckriet, Amy Walker
  • Publication number: 20210246470
    Abstract: A ribonucleoprotein (RNP) delivery system comprising (a) a cationic lipid; (b) a phospholipid; (c) a peptide of the structure A-B-C in which A is a polycationic nucleic acid-binding component, B is a spacer element comprising two or more amino acid residues, and C is a cell surface receptor binding component; and (d) a ribonucleoprotein (RNP) complex comprising a CRISPR-associated protein and guide RNA, pharmaceutical compositions comprising such a ribonucleoprotein (RNP) delivery system, and methods for the treatment or prophylaxis of a condition caused in a human or in a non-human animal by a defect and/or a deficiency in a gene, or for RNA therapy, or for the treatment of a cancer, which comprises administering the RNP delivery system or pharmaceutical composition to the human or to the non-human animal.
    Type: Application
    Filed: March 1, 2019
    Publication date: August 12, 2021
    Inventors: Stephen Lewis HART, Ahmad Mohammed ALDOSSARY, Amy WALKER
  • Patent number: D1007814
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: December 19, 2023
    Inventor: Amy Walker